Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Buy
54
NVMI Quote, Financials, Valuation and Earnings
Last price:
$185.85
Seasonality move
:
3.54%
Day range:
$192.64 - $199.33
52-week range:
$158.00 - $289.90
Dividend yield:
0%
P/E ratio:
33.59x
P/S ratio:
9.20x
P/B ratio:
6.09x
Volume:
348.5K
Avg. volume:
338.5K
1-year change:
7.28%
Market cap:
$5.6B
Revenue:
$672.4M
EPS (TTM):
$5.74
Analysts' Opinion
-
Consensus RatingNova has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $283.02, Nova has an estimated upside of 46.77% from its current price of $192.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $186.12 representing 100% downside risk from its current price of $192.83.
Fair Value
-
According to the consensus of 8 analysts, Nova has 46.77% upside to fair value with a price target of $283.02 per share.
NVMI vs. S&P 500
-
Over the past 5 trading days, Nova has underperformed the S&P 500 by -4.48% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nova does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nova has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Nova reported revenues of $194.8M.
Earnings Growth
-
Nova has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Nova reported earnings per share of $1.58.
Enterprise value:
5.2B
EV / Invested capital:
4.73x
Price / LTM sales:
9.20x
EV / EBIT:
27.94x
EV / Revenue:
7.79x
PEG ratio (5yr expected):
1.01x
EV / Free cash flow:
24.03x
Price / Operating cash flow:
28.36x
Enterprise value / EBITDA:
25.57x
Gross Profit (TTM):
$387.1M
Return On Assets:
14.6%
Net Income Margin (TTM):
27.33%
Return On Equity:
21.77%
Return On Invested Capital:
17.69%
Operating Margin:
28.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $570.7M | $517.9M | $672.4M | $134.2M | $194.8M | |
| Gross Profit | $317M | $293.2M | $387.1M | $74M | $109.9M | |
| Operating Income | $149.9M | $132.3M | $187.5M | $33.7M | $55.5M | |
| EBITDA | $164.6M | $148.5M | $204.9M | $37.9M | $59.8M | |
| Diluted EPS | $4.40 | $4.31 | $5.74 | $1.20 | $1.58 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $558.7M | $566.5M | $612.9M | $710.2M | $901.9M | |
| Total Assets | $655.8M | $805.2M | $984.1M | $1.1B | $1.4B | |
| Current Liabilities | $60.9M | $287.9M | $134.1M | $322.8M | $388.2M | |
| Total Liabilities | $284.2M | $331.4M | $397.1M | $383.1M | $462.6M | |
| Total Equity | $371.5M | $473.8M | $587M | $750.8M | $927.8M | |
| Total Debt | $178.8M | $183M | $196.4M | $197.7M | $180.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $119.5M | $123.5M | $235.3M | $29.6M | $68.5M | |
| Cash From Investing | -$100.3M | -$125.3M | -$136.4M | -$38.5M | -$15.2M | |
| Cash From Financing | -$29.8M | $10K | -$48.3M | -- | -$48.4M | |
| Free Cash Flow | $98.2M | $106.3M | $218.1M | $22M | $60.4M | |
NVMI
Sector
Market Cap
$5.6B
$87.5M
Price % of 52-Week High
66.52%
60.21%
Dividend Yield
0%
0%
Shareholder Yield
0.58%
0.8%
1-Year Price Total Return
7.28%
-16.45%
Beta (5-Year)
1.458
0.910
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$198.80
200-day SMA
Sell
Level
$213.32
Bollinger Bands (100)
Sell
Level
186.19 - 241.37
Chaikin Money Flow
Buy
Level
35.6M
20-day SMA
Sell
Level
$213.29
Relative Strength Index (RSI14)
Sell
Level
35.05
ADX Line
Sell
Level
22.35
Williams %R
Buy
Level
-98.0935
50-day SMA
Sell
Level
$234.74
MACD (12, 26)
Sell
Level
-11.56
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
48.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.6544)
Buy
CA Score
(Annual)
Level (1.171)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-2.3769)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.
Stock Forecast FAQ
In the current month, NVMI has received 6 Buy ratings 2 Hold ratings, and 0 Sell ratings. The NVMI average analyst price target in the past 3 months is $283.02.
-
Where Will Nova Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nova share price will rise to $283.02 per share over the next 12 months.
-
What Do Analysts Say About Nova?
Analysts are divided on their view about Nova share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nova is a Sell and believe this share price will drop from its current level to $186.12.
-
What Is Nova's Price Target?
The price target for Nova over the next 1-year time period is forecast to be $283.02 according to 8 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is NVMI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nova is a Buy. 6 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NVMI?
You can purchase shares of Nova via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nova shares.
-
What Is The Nova Share Price Today?
Nova was last trading at $185.85 per share. This represents the most recent stock quote for Nova. Yesterday, Nova closed at $192.83 per share.
-
How To Buy Nova Stock Online?
In order to purchase Nova stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 13.99% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.83% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is down 0.82% over the past day.
